New COVID-19 Wave Hits Hong Kong And Singapore: JN.1 Variant Spreading Fast — Can Existing COVID Vaccines Protect You?

JN.1, a variant of Omicron BA.2.86, emerged in late 2023 with 30 immune-evasion mutations. It spreads more efficiently due to additional mutations, says Johns Hopkins University.

COVID-19 New Wave: The world is still dealing with the harm that the covid 19 pandemic has caused be it economic, mental or infrastructural and now there are concerns over another forthcoming crisis of another covid wave, this a fresh wave of the pandemic has surfaced in parts of Asia, signaling alarms for looming concerns over countries such as Singapore, Hong Kong, China, and Thailand as the countries are seeing a sudden increase in new infections.

According to the experts, the spread of infection and the surge is largely rooted in the spread of new Omicron subvariants, which include the JN.1 and its further linked variants, which have made the authorities on their toes and look deeper into the cases to restrict any possible mass level outbreak.

Countries like Hong Kong and Singapore are facing the brunt of the virus as the number of cases rose by 28% in Singapore, while Hong Kong logged 31 severe cases in just a week. Moreover, considering the surge in infection rate, Singapore has been kept on high alert, underlining the assumption that the number of Covid-19 cases in the week ending on May 3 went up to 14,200 from 11,100 a week before, and the rate of hospitalisation has gone up by 30 per cent.

With 31 deaths reported in the week ending on May 3, the economic hub, Hong Kong, sees an unusual rise in cases as compared to the recent past year.

The Continent of Asia, more specifically the South-east Asia is under the radar when it comes to the worsening COVID situation, the public is apprehensive of another possible lockdown while the governments raise concerns over the mass lever management during another possible pandemic.

The situation is not just circumscribed to Singapore and Hong Kong but other Asian countries have also reported a rise in the cases.

What Variants Are Affecting Which Countries?

The prevalent variants at the moment are LF.7 and NB.1.8, both rooted in the JN.1. Countries like Singapore are on high alert for COVID-19 as the cases have rapidly increased. The daily hospitalisation in Singapore has reached from 102 to133 but what moderates the situation is the fall in ICU admissions rate from 3 to 2. Singapore's Ministry of Health has claimed that LF.7 and NB.1.8, rooted to the JN.1 variant which is being used in the latest Covid-19 vaccines, were circulating in the country.

In Hong Kong, with 13.66% of cases being reported to be positive in the week that ended on May 10 and 81 severe cases, with 30 deaths, Hong Kong is seeing a grave situation. The health officials are trying to manage the situation at its earliest. The Chinese Centre for Disease Control and Prevention has said that the number of cases that are coming positive has doubled. Apart from these countries, Thailand is too on the threshold of a rising rate of the Covid infection.

In India, the city of Dreams, Mumbai has seen a surge in infection rate but it is highly restricted to youngsters. Indian health authorities have stated no such significant rise in the country. According to The Ministry of Health and Family Welfare, in India, there are 93 active COVID-19 cases in the country as of 19 May 2025.

What Is JN.1 COVID-19 Variant: Why Is It So Dangerous?

JN.1 originated from the Omicron BA.2.86 lineage that became known in August 2023. The World Health Organisation claimed it as the Variant of Interest in December 2023. This variant shows an estimate of 30 mutations which threatens to evade immunity more than any other variant circulating at that time. However, the BA.2.86 didn't end up being mass-level threatening.

The Johns Hopkins University has observed the efficiency of the latest variant, the JN.1. It has advanced by a few mutations, making it more transmissible, and it threatens immunity.

According to multiple research, the earlier covid 19 vaccines have been recorded to be more inefficient at restricting the JN.1 as compared to earlier variants. However, The WHO has said that the XBB.1.5 monovalent booster, a Covid-19 vaccine that was made to target the XBB.1.5 subvariant of Omicron, has been proven to shield against the latest variant, the JN.1. In India As of now, the Covovax XBB.1.5 monovalent booster is the only COVID-19 vaccine available to protect against the Omicron XBB.1.5 subvariant.

Symptoms of the JN.1 COVID-19 Variant Infection

The symptoms of JN.1 are largely identical to other COVID-19 variants, including runny or blocked nose, dry cough, sore throat, rise in body temperature, lethargy or fatigue, loss of taste or smell, muscle pain, diarrhea, vomiting and even headache, the severe cases may show breathlessness as a symptom.

Despite the surge in the Infection rate, the countries this time are calmer, underlining the preparedness that the past variants have caused. In India, the government is monitoring the situation and trying to prevent the outbreak.

Follow TheHealthSite.com for all the latest health news and developments from around the world.